certify

Nqaba Matshazi Nqaba has been working as an investigative journalist for the last 10 years. He has written for various media outlets across the world.

September 15, 2023 193 Views
Roche was supposed to receive the FDA decision regarding the subcutaneous version of its cancer immunotherapy Tecentriq last ...
June 14, 2019 879 Views
Swiss drugmaker, Roche was hoping to tie up the acquisition of gene therapy firm, Spark Therapeutics for $4.8 ...
banner
Adsense